Safety of sublingual immunotherapy with a monomeric allergoid in very young children.
Agostinis
F
F
Allergy & Respiratory Diseases Department of Internal Medicine Padiglione Maragliano L.go R. Benzi 10 16132 Genoa Italy.
Tellarini
L
L
Canonica
G W
GW
Falagiani
P
P
Passalacqua
G
G
D000286:Administration, Sublingual; D000080384:Allergoids; D001249:Asthma / Q000209:etiology*; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000628:therapy; D003888:Desensitization, Immunologic / Q000009:adverse effects* / Q000379:methods*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000628:therapy*; D007223:Infant; D008297:Male; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects*; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy
D000080384:Allergoids; D010936:Plant Extracts